|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fiala O, Šorejs O, Pešek M and Fínek J:
Immunotherapy in the treatment of lung cancer. Klin Onkol. 30
(Supplementum3):S22–S31. 2017.(In Czech). View Article : Google Scholar
|
|
4
|
Ren Y, Li Y and Tian D: Role of the ABCE1
gene in human lung adenocarcinoma. Oncol Rep. 27:965–970. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen ZQ, Dong J, Ishimura A, Daar I,
Hinnebusch AG and Dean M: The essential vertebrate ABCE1 protein
interacts with eukaryotic initiation factors. J Biol Chem.
281:7452–7457. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Becker T, Franckenberg S, Wickles S,
Shoemaker CJ, Anger AM, Armache JP, Sieber H, Ungewickell C,
Berninghausen O, Daberkow I, et al: Structural basis of highly
conserved ribosome recycling in eukaryotes and archaea. Nature.
482:501–506. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang B, Gao Y, Tian D and Zheng M: A
small interfering ABCE1-targeting RNA inhibits the proliferation
and invasiveness of small cell lung cancer. Int J Mol Med.
25:687–693. 2010.PubMed/NCBI
|
|
8
|
Creppe C, Malinouskaya L, Volvert ML,
Gillard M, Close P, Malaise O, Laguesse S, Cornez I, Rahmouni S,
Ormenese S, et al: Elongator controls the migration and
differentiation of cortical neurons through acetylation of
alpha-tubulin. Cell. 136:551–564. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhuang S: Regulation of STAT signaling by
acetylation. Cell Signal. 25:1924–1931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang W, Wang Z and Lei QY: Acetylation
control of metabolic enzymes in cancer: An updated version. Acta
Biochim Biophys Sin (Shanghai). 46:204–213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi M, Lu XJ, Zhang J, Diao H, Li G, Xu L,
Wang T, Wei J, Meng W, Ma JL, et al: Oridonin, a novel lysine
acetyltransferases inhibitor, inhibits proliferation and induces
apoptosis in gastric cancer cells through p53- and
caspase-3-mediated mechanisms. Oncotarget. 7:22623–22631.
2016.PubMed/NCBI
|
|
12
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang X, Wu J and Luan Y: Tip60: Main
functions and its inhibitors. Mini Rev Med Chem. 17:675–682. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun Y, Jiang X, Xu Y, Ayrapetov MK, Moreau
LA, Whetstine JR and Price BD: Histone H3 methylation links DNA
damage detection to activation of the tumour suppressor Tip60. Nat
Cell Biol. 11:1376–1382. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen G, Cheng Y, Tang Y, Martinka M and Li
G: Role of Tip60 in human melanoma cell migration, metastasis, and
patient survival. J Invest Dermatol. 132:2632–2641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brown JA, Bourke E, Eriksson LA and Kerin
MJ: Targeting cancer using KAT inhibitors to mimic lethal
knockouts. Biochem Soc Trans. 44:979–986. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang L, Du Y, Lu M and Li T: ASEB: A web
server for KAT-specific acetylation site prediction. Nucleic Acids
Res 40 (Web Server issue). W376–W379. 2012. View Article : Google Scholar
|
|
18
|
Shiota M, Yokomizo A, Masubuchi D, Tada Y,
Inokuchi J, Eto M, Uchiumi T, Fujimoto N and Naito S: Tip60
promotes prostate cancer cell proliferation by translocation of
androgen receptor into the nucleus. Prostate. 70:540–554.
2010.PubMed/NCBI
|
|
19
|
Socinski MA, Obasaju C, Gandara D, Hirsch
FR, Bonomi P, Bunn PA Jr, Kim ES, Langer CJ, Natale RB, Novello S,
et al: Current and emergent therapy options for advanced squamous
cell lung cancer. J Thorac Oncol. 13:165–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zappa C and Mousa SA: Non-small cell lung
cancer: Current treatment and future advances. Transl Lung Cancer
Res. 5:288–300. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martínez-Reyes I and Chandel NS:
Acetyl-CoA-directed gene transcription in cancer cells. Genes Dev.
32:463–465. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lovinsky-Desir S and Miller RL:
Epigenetics, asthma, and allergic diseases: A review of the latest
advancements. Curr Allergy Asthma Rep. 12:211–220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garagnani P, Pirazzini C and Franceschi C:
Colorectal cancer microenvironment: Among nutrition, gut
microbiota, inflammation and epigenetics. Curr Pharm Des.
19:765–778. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang K, Tian S and Fan E: Protein lysine
acetylation analysis: Current MS-based proteomic technologies.
Analyst. 138:1628–1636. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shanmugam MK, Arfuso F, Arumugam S,
Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS,
Sethi G and Lakshmanan M: Role of novel histone modifications in
cancer. Oncotarget. 9:11414–11426. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirano G, Izumi H, Kidani A, Yasuniwa Y,
Han B, Kusaba H, Akashi K, Kuwano M and Kohno K: Enhanced
expression of PCAF endows apoptosis resistance in
cisplatin-resistant cells. Mol Cancer Res. 8:864–872. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shiota M, Yokomizo A, Tada Y, Uchiumi T,
Inokuchi J, Tatsugami K, Kuroiwa K, Yamamoto K, Seki N and Naito S:
P300/CBP-associated factor regulates Y-box binding protein-1
expression and promotes cancer cell growth, cancer invasion and
drug resistance. Cancer Sci. 101:1797–1806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang
Q, Lin Y, Li J, Kang T, Tao M, et al: Disrupting the interaction of
BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like
breast cancer. Cancer Cell. 25:210–225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patel JH, Du Y, Ard PG, Phillips C,
Carella B, Chen CJ, Rakowski C, Chatterjee C, Lieberman PM, Lane
WS, et al: The c-MYC oncoprotein is a substrate of the
acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol.
24:10826–10834. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gorrini C, Squatrito M, Luise C, Syed N,
Perna D, Wark L, Martinato F, Sardella D, Verrecchia A, Bennett S,
et al: Tip60 is a haplo-insufficient tumour suppressor required for
an oncogene-induced DNA damage response. Nature. 448:1063–1067.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang B, Zhou H, Lang X and Liu Z:
siRNA-induced ABCE1 silencing inhibits proliferation and invasion
of breast cancer cells. Mol Med Rep. 10:1685–1690. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qu X and Zhang L: Effect of
ABCE1-silencing gene, transfected by electrotransfer, on the
proliferation, invasion, and migration of human thyroid carcinoma
SW579 cells. Genet Mol Res. 14:14680–14689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Judes G, Rifaï K, Ngollo M, Daures M,
Bignon YJ, Penault-Llorca F and Bernard-Gallon D: A bivalent role
of TIP60 histone acetyl transferase in human cancer. Epigenomics.
7:1351–1363. 2015. View Article : Google Scholar : PubMed/NCBI
|
